Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Hay, Deborah
and
Weatherall, David J
2001.
eLS.
p.
1.
Di Marzo, Rosalba
Calzolari, Roberta
Rund, Deborah
and
Maggio, Aurelio
2010.
Encyclopedia of Life Sciences.
Weatherall, David J
2010.
Encyclopedia of Life Sciences.
2010.
Variant Haemoglobins.
p.
1.
Steinberg, Martin H.
McCarthy, William F.
Castro, Oswaldo
Ballas, Samir K.
Armstrong, F. Danny
Smith, Wally
Ataga, Kenneth
Swerdlow, Paul
Kutlar, Abdullah
DeCastro, Laura
and
Waclawiw, Myron A.
2010.
The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up.
American Journal of Hematology,
Vol. 85,
Issue. 6,
p.
403.
Thein, Swee Lay
and
Rees, David
2010.
Postgraduate Haematology.
p.
83.
2010.
Variant Haemoglobins.
p.
9.
Akinsheye, Idowu
Alsultan, Abdulrahman
Solovieff, Nadia
Ngo, Duyen
Baldwin, Clinton T.
Sebastiani, Paola
Chui, David H. K.
and
Steinberg, Martin H.
2011.
Fetal hemoglobin in sickle cell anemia.
Blood,
Vol. 118,
Issue. 1,
p.
19.
Musallam, Khaled M.
and
Taher, Ali T.
2011.
Thrombosis in Thalassemia: Why are we so Concerned?.
Hemoglobin,
Vol. 35,
Issue. 5-6,
p.
503.
Musallam, Khaled M.
Khoury, Brigitte
Abi-Habib, Rudy
Bazzi, Lama
Succar, Julien
Halawi, Racha
Hankir, Ahmed
Koussa, Suzanne
and
Taher, Ali T.
2011.
Health-related quality of life in adults with transfusion-independent thalassaemia intermedia compared to regularly transfused thalassaemia major: new insights.
European Journal of Haematology,
Vol. 87,
Issue. 1,
p.
73.
Agarwal, Archana M.
and
Prchal, Josef T.
2011.
Concise Guide to Hematology.
p.
62.
Taher, Ali T.
Musallam, Khaled M.
Cappellini, Maria Domenica
and
Weatherall, David J.
2011.
Optimal management of β thalassaemia intermedia.
British Journal of Haematology,
Vol. 152,
Issue. 5,
p.
512.
PHYLIPSEN, M.
GALLIVAN, M. V. E.
ARKESTEIJN, S. G. J.
HARTEVELD, C. L.
and
GIORDANO, P. C.
2011.
Occurrence of common and rare δ‐globin gene defects in two multiethnic populations: thirteen new mutations and the significance of δ‐globin gene defects in β‐thalassemia diagnostics.
International Journal of Laboratory Hematology,
Vol. 33,
Issue. 1,
p.
85.
Steinberg, Martin H.
and
Sebastiani, Paola
2012.
Genetic modifiers of sickle cell disease.
American Journal of Hematology,
Vol. 87,
Issue. 8,
p.
795.
Park, Seungman
Park, Jun Eun
Cho, Sung Im
Jeon, Yongbum
Park, Sung Sup
and
Seong, Moon-Woo
2012.
The First Study on Nucleotide-level Identification of Hb Koriyama in a Patient with Severe Hemolytic Anemia.
Annals of Laboratory Medicine,
Vol. 32,
Issue. 1,
p.
99.
Khandros, Eugene
Thom, Christopher S.
D'Souza, Janine
and
Weiss, Mitchell J.
2012.
Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia.
Blood,
Vol. 119,
Issue. 22,
p.
5265.
Musallam, Khaled M.
Nasreddine, Wassim
Beydoun, Ahmad
Hourani, Roula
Hankir, Ahmed
Koussa, Suzanne
Haidar, Mohamad
and
Taher, Ali T.
2012.
Brain positron emission tomography in splenectomized adults with β-thalassemia intermedia: uncovering yet another covert abnormality.
Annals of Hematology,
Vol. 91,
Issue. 2,
p.
235.
Musallam, Khaled M.
Taher, Ali T.
Cappellini, Maria Domenica
and
Sankaran, Vijay G.
2013.
Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia.
Blood,
Vol. 121,
Issue. 12,
p.
2199.
Elalfy, Mohsen S.
Adly, Amira A. M.
Ismail, Eman A.
Elhenawy, Yasmine I.
and
Elghamry, Islam R.
2013.
Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β‐thalassemia intermedia patients.
European Journal of Haematology,
Vol. 91,
Issue. 6,
p.
522.
Kountouris, Petros
Lederer, Carsten W.
Fanis, Pavlos
Feleki, Xenia
Old, John
Kleanthous, Marina
and
de Brevern, Alexandre G.
2014.
IthaGenes: An Interactive Database for Haemoglobin Variations and Epidemiology.
PLoS ONE,
Vol. 9,
Issue. 7,
p.
e103020.